Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Key Medical Technologies Inc. currently manages 1 pending office action within the Chemistry & Materials technology area. This single action represents the current scope of the company's active patent prosecution before the USPTO. The focus on Chemistry & Materials suggests that the company's intellectual property efforts are concentrated within this specific technical domain at this time.
The portfolio's activity is limited to 1 distinct examiner and 1 distinct art unit. This concentration indicates a highly centralized review process, where the entirety of the company's pending workload is subject to the oversight of a single individual within one technical department. For the practitioner, this structure simplifies the administrative management of the portfolio as there are no competing examiner requirements to balance.
Alicia Bland is identified as the busiest examiner for the company, with 1 pending office action. Since there is only 1 pending office action in total, this examiner is the sole point of contact for the company's current USPTO matters. Success in this portfolio depends on navigating the specific preferences and prior art interpretations of this one examiner to effectively advance the company's patent interests.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BLAND, ALICIA | 1 | 50.8% | +12.9% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18047865 | BIOACTIVE POLYMERS FOR OPHTHALMIC APPLICATIONS | BLAND, ALICIA | 11d overdue |
| Art Unit | Apps |
|---|---|
| 1759 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18047865 | BIOACTIVE POLYMERS FOR OPHTHALMIC APPLICATIONS | BLAND, ALICIA | 1759 | §102 | Final Rejection | 11d overdue | Pending | Oct 19, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKey Medical Technologies Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Alicia Bland has the most, with 1 of Key Medical Technologies Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.